Global Precision Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Precision Medicine Market is presumed to reach the market size of nearly USD 169.88 Billion by 2032 from USD 84.21 Billion in 2023 with a CAGR of 8.11% under the study period 2024-2032.

The precision medicine, also known as personalized medicines, is the upcoming trend in the healthcare sector that grows rapidly over the years. Precision medicine is based on a unique concept that defines, two people infected with the same disease don't need to have the same physical response toward the disorder. However, it depends on the surrounding environment and the influence of genes and symptoms of the patient. Moreover, it also depends on patients' ability to respond to that particular disease, enabling the doctors and researchers to organize the necessary treatment. Precision medicine mainly includes system biology and panomics to examine the reason for an individual patient's illness at the molecular level. Followed by the use of concentrated medications to address individual patient's ailments. Precision medicine offers many benefits, such as efficient treatment customized to patients' needs and disease categories. Moreover, precision medicine can reduce the cost of treatment and help decrease repeated administration of medications.

MARKET DYNAMICS

The market is mainly driven by increasing approval of the drug and its companion diagnostic assay, cost-effective profiling of DNA, increasing incidence of cancer, and the rise of data-driven healthcare. In addition, the rising use of "multi-omics" in research, along with the penetration of high-throughput sequencing platforms, is also surging up the precision medicine scenario. The number of targeted molecules in the pipeline for a specific application has been exponentially growing, specifically in oncology has created a new opportunity over the forecast period. The current escalating price of drug discovery and increasing regulatory requirements have increased the demand for an individualized product. The development of companion diagnostics appears to offer a set of tools and relevant clinical and biological information to address various pharmaceutical companies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Precision Medicine. The growth and trends of Precision Medicine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Precision Medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests)
Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics)

By Indication

Oncology
CNS Disorders
Immunology
Respiratory Diseases
Genetic Disorders
Skin Diseases
Other Indications

By Technology

Genomics
Bioinformatics
Big Data Analytics
Biomarker Detection
High Throughput Screening
Other Technologies

By End-User

Hospitals
Diagnostic Laboratories
Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Precision Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Precision Medicine market include Abbott Laboratories Inc., Abbie Inc., AstraZeneca Plc, BioMerieux SA, Bristol-Myers Squibb Company, Cepheid (Danaher Corporation), EliLilly & Company, F. Hoffmann-La Roche, GlaxoSmithKline Plc, Laboratory Corporation Of America Holdings (Covance Inc.), Myriad Genetics Inc., Novartis AG, Pfizer Inc., QIAGEN NV., Quest Diagnostics, Takeda Pharmaceutical Company Limited, ThermFisher Scientific Inc., Vyant Bio Inc. (Cancer Genetics Inc.). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11214898

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PRECISION MEDICINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Technology
- 3.7.4 Market Attractiveness Analysis By End-User
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Diagnostics (Genetic Tests, Biomarker Based Tests, Esoteric Tests, Other Tests) Historic and Forecast Sales By Regions
5.4. Therapeutics (Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-Retroviral Drugs, Other Therapeutics) Historic and Forecast Sales By Regions

6. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY INDICATION

6.1. Overview By Indication
6.2. Historical and Forecast Data Analysis By Indication
6.3. Oncology Historic and Forecast Sales By Regions
6.4. CNS Disorders Historic and Forecast Sales By Regions
6.5. Immunology Historic and Forecast Sales By Regions
6.6. Respiratory Diseases Historic and Forecast Sales By Regions
6.7. Genetic Disorders Historic and Forecast Sales By Regions
6.8. Skin Diseases Historic and Forecast Sales By Regions
6.9. Other Indications Historic and Forecast Sales By Regions

7. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY TECHNOLOGY

7.1. Overview By Technology
7.2. Historical and Forecast Data Analysis By Technology
7.3. Genomics Historic and Forecast Sales By Regions
7.4. Bioinformatics Historic and Forecast Sales By Regions
7.5. Big Data Analytics Historic and Forecast Sales By Regions
7.6. Biomarker Detection Historic and Forecast Sales By Regions
7.7. High Throughput Screening Historic and Forecast Sales By Regions
7.8. Other Technologies Historic and Forecast Sales By Regions

8. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY END-USER

8.1. Overview By End-User
8.2. Historical and Forecast Data Analysis By End-User
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Diagnostic Laboratories Historic and Forecast Sales By Regions
8.5. Other End-Users Historic and Forecast Sales By Regions

9. GLOBAL PRECISION MEDICINE MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PRECISION MEDICINE COMPANIES

10.1. Precision Medicine Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PRECISION MEDICINE INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Abbott Laboratories Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Abbie Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. AstraZeneca Plc
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. BioMerieux SA
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Bristol-Myers Squibb Company
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Cepheid (Danaher Corporation)
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. EliLilly & Company
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. F. Hoffmann-La Roche
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. GlaxoSmithKline Plc
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Laboratory Corporation Of America Holdings (Covance Inc.)
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Myriad Genetics Inc.
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Novartis AG
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Pfizer Inc.
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. QIAGEN NV.
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. Quest Diagnostics
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments
11.18. Takeda Pharmaceutical Company Limited
- 11.18.1 Company Overview
- 11.18.2 Company Revenue
- 11.18.3 Products
- 11.18.4 Recent Developments
11.19. ThermFisher Scientific Inc.
- 11.19.1 Company Overview
- 11.19.2 Company Revenue
- 11.19.3 Products
- 11.19.4 Recent Developments
11.20. Vyant Bio Inc. (Cancer Genetics Inc.)
- 11.20.1 Company Overview
- 11.20.2 Company Revenue
- 11.20.3 Products
- 11.20.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies